Axcan Pharma, Inc.
2Patents
1Active
2Granted
34Portfolio score
Filing activity: Jun 16, 2000 → Oct 3, 2008 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6350468B1 | Double capsule for the administration of active principles in multiple therapies | Human Necessities | 19 | Expired |
| US7541384B2 | Mesalamine suppository | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.